Annual Total Liabilities
$101.39 M
+$7.46 M+7.95%
December 31, 2023
Summary
- As of February 7, 2025, CTKB annual total liabilities is $101.39 million, with the most recent change of +$7.46 million (+7.95%) on December 31, 2023.
- During the last 3 years, CTKB annual total liabilities has fallen by -$134.61 million (-57.04%).
- CTKB annual total liabilities is now -57.04% below its all-time high of $236.01 million, reached on December 31, 2020.
Performance
CTKB Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$105.76 M
+$11.16 M+11.80%
September 30, 2024
Summary
- As of February 7, 2025, CTKB quarterly total liabilities is $105.76 million, with the most recent change of +$11.16 million (+11.80%) on September 30, 2024.
- Over the past year, CTKB quarterly total liabilities has increased by +$1.86 million (+1.79%).
- CTKB quarterly total liabilities is now -56.16% below its all-time high of $241.26 million, reached on June 30, 2021.
Performance
CTKB Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
CTKB Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.0% | +1.8% |
| 3 y3 years | -57.0% | +4.8% |
| 5 y5 years | -9.5% | +4.8% |
CTKB Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +75.1% | at high | +82.6% |
| 5 y | 5-year | -57.0% | +75.1% | -56.2% | +106.9% |
| alltime | all time | -57.0% | +75.1% | -56.2% | +106.9% |
Cytek Biosciences Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $105.76 M(+11.8%) |
| Jun 2024 | - | $94.60 M(-4.9%) |
| Mar 2024 | - | $99.45 M(-1.9%) |
| Dec 2023 | $101.39 M(+7.9%) | $101.39 M(-2.4%) |
| Sep 2023 | - | $103.91 M(+3.0%) |
| Jun 2023 | - | $100.88 M(-0.2%) |
| Mar 2023 | - | $101.11 M(+7.6%) |
| Dec 2022 | $93.93 M | $93.93 M(+13.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $82.79 M(+1.3%) |
| Jun 2022 | - | $81.69 M(+4.1%) |
| Mar 2022 | - | $78.44 M(+35.4%) |
| Dec 2021 | $57.92 M(-75.5%) | $57.92 M(+13.3%) |
| Sep 2021 | - | $51.13 M(-78.8%) |
| Jun 2021 | - | $241.26 M(+0.9%) |
| Mar 2021 | - | $239.02 M(+1.3%) |
| Dec 2020 | $236.01 M(+110.6%) | $236.01 M |
| Dec 2019 | $112.06 M | - |
FAQ
- What is Cytek Biosciences annual total liabilities?
- What is the all time high annual total liabilities for Cytek Biosciences?
- What is Cytek Biosciences annual total liabilities year-on-year change?
- What is Cytek Biosciences quarterly total liabilities?
- What is the all time high quarterly total liabilities for Cytek Biosciences?
- What is Cytek Biosciences quarterly total liabilities year-on-year change?
What is Cytek Biosciences annual total liabilities?
The current annual total liabilities of CTKB is $101.39 M
What is the all time high annual total liabilities for Cytek Biosciences?
Cytek Biosciences all-time high annual total liabilities is $236.01 M
What is Cytek Biosciences annual total liabilities year-on-year change?
Over the past year, CTKB annual total liabilities has changed by +$7.46 M (+7.95%)
What is Cytek Biosciences quarterly total liabilities?
The current quarterly total liabilities of CTKB is $105.76 M
What is the all time high quarterly total liabilities for Cytek Biosciences?
Cytek Biosciences all-time high quarterly total liabilities is $241.26 M
What is Cytek Biosciences quarterly total liabilities year-on-year change?
Over the past year, CTKB quarterly total liabilities has changed by +$1.86 M (+1.79%)